December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Photodynamic Therapy (PDT) in Multifocal Choroiditis (MFC)
Author Affiliations & Notes
  • MT Tennant
    Retina Service Wills Eye Hospital Philadelphia PA
  • M Shuler
    Retina Service Wills Eye Hospital Philadelphia PA
  • A Martidis
    Retina Service Wills Eye Hospital Philadelphia PA
  • JB Belmont
    Retina Service Wills Eye Hospital Philadelphia PA
  • WE Benson
    Retina Service Wills Eye Hospital Philadelphia PA
  • Footnotes
    Commercial Relationships   M.T. Tennant, None; M. Shuler, None; A. Martidis, None; J.B. Belmont, None; W.E. Benson, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 595. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      MT Tennant, M Shuler, A Martidis, JB Belmont, WE Benson; Photodynamic Therapy (PDT) in Multifocal Choroiditis (MFC) . Invest. Ophthalmol. Vis. Sci. 2002;43(13):595.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To describe the treatment of MFC-associated choroidal neovascularization (CNV) with PDT Methods: Single case report of a patient with MFC and sequential bilateral peripapillary CNV treated with subtenons and intravitreal triamcinolone (IVT), followed by PDT for juxtafoveal CNV with 1 year follow-up. Results: A 35 year old, healthy male presented with poor vision in the left eye due to large peripapillary CNV that had extended into the subfoveal space (visual acuity 20/400 OD, 20/20 OS). Subtenons triamcinolone injection(1mg) was performed but vision continued to deteriorate to counting fingers in the left eye. IVT OS (4mg) resulted in resolution of CNV leakage and improvement in vision (visual acuity 20/200). On follow-up, an initially small peripapillary CNV in the right eye showed active growth toward the fovea despite IVT (4mg) and underwent PDT for juxtapapillary CNV (visual acuity 20/40). Six weeks later the patient’s symptoms had resolved with no active leakage on Fluorescein Angiography (visual acuity 20/25). One month later, the patient noted loss of visual field with metamorphopsia of the right eye. Repeat Fluorescein Angiography demonstrated reactivation of the juxtafoveal CNV with symptomatic visual field loss (visual acuity 20/20)(Figure 1). Repeat PDT was performed two weeks later to the CNV Complex. Follow up one month later demonstrated symptomatic improvement and no leakage. The patient was followed on a monthly basis for another two months with maintenance of 20/20 vision in the right eye and stable 20/400 vision in the left eye. Conclusion: We report the use of PDT in treating MFC-associated CNV with stabilization of vision and clinical exam. Figure 1. Color photograph of CNV complex prior to second PDT Treatment (Visual acuity 20/20)  

Keywords: 346 choroid: neovascularization • 344 chorioretinitis • 516 photodynamic therapy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×